Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms

Authors:

Abstract
An estimated 40% to 54% of postmenopausal women report bothersome vulvovaginal symptoms,1-3 including vaginal dryness (up to 75%) and pain with intercourse (40%).2,4,5 In 2014, the North American Menopause Society coined the term genitourinary syndrome of menopause (GSM) to reflect the multifaceted nature of this prevalent problem, replacing genitourinary and vulvovaginal atrophy.6 Recent evidence shows decrements in quality of life from moderate to severe vulvovaginal symptoms in women aged 40 to 75 years comparable to those caused by other chronic conditions such as arthritis, chronic obstructive pulmonary disease, and irritable bowel syndrome.1 Yet more than half of symptomatic women are not using any medication to treat their symptoms.7,8

This publication has 48 references indexed in Scilit: